Pieter is Managing Director at Gilde Healthcare Partners B.V., where he has focused on investments in pharmaceutical and biotechnology based companies. Pieter joined Gilde in 1998 after several years working with KPMG Management Consulting where he led due diligence projects in the pharmaceutical and environmental sector. Pieter holds an MSc in chemistry from Leiden University, where he specialised in bio-organic synthesis and molecular modelling and also holds a degree in commercial economics. Pieter led investments in Ablynx NV, Agendia B.V., BG Medicine Inc., CropDesign NV and Inpharmatica. He represented Gilde on the boards of Ablynx, BG Medicine, CropDesign and Inpharmatica Ltd and is currently on the board of Agendia B.V. and Gilde.